Biotech
Regulatory
Sanofi’s Supemtek (quadrivalent recombinant influenza vaccine) Receives the EC’s Approval
Shots: The approval is based on two P-III studies assessing the safety and efficacy of Supemtek (quadrivalent recombinant influenza vaccine) in 10,000 patients with influenza aged > 18yrs. Supemtek is […]readmore